CONCLUSION: CIK cells have strong proliferative ability and higher cytotoxicity to tumor cells in vitro, which could be used as a potential anti-tumor adoptive immunotherapy in clinic.
结论:CIK细胞在体外扩增能力强,对肿瘤细胞的杀伤活性高,有望成为新一代抗肿瘤过继免疫细胞制剂而应用于临床。
Preventing hepatitis C virus recurrence in liver transplant recipients: A role for adoptive immunotherapy?
在肝移植受体中,预防丙肝病毒复发:过继免疫治疗的作用吗?
Objective To investigate the effects and the mechanisms of local adoptive immunotherapy of murine bladder cancer with interleukin-4 (IL-4).
目的观察白细胞介素4(IL-4)局部过继免疫治疗小鼠膀胱癌的效应并探讨其相关机制。
The use of adoptive immunotherapy involving expanded anti-leukemia cytotoxic t cells may offer a reasonable approach to eliminate residual disease in these patients.
采用过继性免疫治疗,输注抗白血病特异性细胞毒性T细胞,可以清除这些患者的残留病灶。
The use of adoptive immunotherapy involving expanded anti-leukemia cytotoxic t cells may offer a reasonable approach to eliminate residual disease in these patients.
采用过继性免疫治疗,输注抗白血病特异性细胞毒性T细胞,可以清除这些患者的残留病灶。
应用推荐